| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 952650-02-1 | (3R)-3-Aminopentanoic acid hydrochloride | C5H11NO2.HCl |
| 952652-79-8 | Valsartan n-propyl;(S)-N-Butyryl-N-([2'-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine | C23H27N5O3 |
| 952664-69-6 | 2-Bromo-5-fluoro-4-nitroaniline;2-Bromo-5-fluoro-4-nitrobenzenamine | C6H4BrFN2O2 |
| 952664-76-5 | N-t-Butyl 2-bromo-4-nitroaniline | |
| 952664-95-8 | 2-(tert-Butyl)-7-fluoro-1H-indol-5-amine | C12H15FN2 |
| 952727-77-4 | 2,4-Dichloro-1-[Isocyano[(4-Methylphenyl)Sulfonyl]Methyl]-Benzene;2,4-DICHLORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE;(2,4-DIMETHYLPHENYL)(ISOCYANO)METHYL 4-METHYLPHENYL SULFONE;1-(2,4-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE | C15H11Cl2NO2S |
| 952800-36-1 | Methyl 7-chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylate;Methyl 7-chloro-1H-pyrrolo[3,2 - b]pyridine-2- carboxylate;Methyl 7-chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylate;Methyl 7-chloro-4-azaindole-2-carboxylate | C9H7ClN2O2 |
| 952800-39-4 | 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid methyl ester | C9H8N2O2 |
| 952901-54-1 | 2-Bromo-4-Iodo-6-(Trifluoromethyl)-Benzenamine | |
| 953039-14-0 | 6-Bromo-2-chloro-8-methoxyquinazoline | C9H6BrClN2O |
| 953039-63-9 | 8-Bromo-2-chloro-6-fluoroquinazoline | C8H3BrClFN2 |
| 953039-66-2 | 7-Bromo-2-chloroquinazoline | C8H4BrClN2 |
| 953039-79-7 | 2-Chloro-7-quinazolinecarboxylic acid methyl ester | C10H7ClN2O2 |
| 953040-54-5 | 1-Methylpyrrole-3-boronic acid, pinacol ester | |
| 953046-62-3 | 3-(2-Fluorophenyl)-5-isoxazolemethanol | C10H8FNO2 |
| 953049-31-5 | 2',3,5-Trifluoro-4''-propyl-[1,1':4',1''-terphenyl]-4-ol | C21H17F3O |
| 953071-73-3 | tert-Butyl 4-(1H-benzimidazol-2-yl)piperidine-1-carboxylate | C17H23N3O2 |
| 953079-94-2 | Pyrrolidine-3-carboxylic acid hydrochloride;beta-Proline hydrochloride | C5H9NO2.HCl |
| 953408-82-7 | 2,3-Dihydro-1-benzofuran-7-sulfonyl chloride;2,3-Dihydro-benzofuran-7-sulfonyl chloride;chloro-2,3-dihydrobenzo[2,3-b]furan-7-ylsulfone | C8H7ClO3S |
| 953409-99-9 | 5-Bromo-1H-indazole-7-carboxylic acid | C8H5BrN2O2 |
| 953411-05-7 | [7-(Methoxycarbonyl)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl]boronic acid;(1-(tert-<wbr>Butoxycar<wbr>bonyl)-7-<wbr>(methoxyc<wbr>arbonyl)-<wbr>1H-indol-<wbr>2-yl)boro<wbr>nic acid;1-BOC-7-(methoxycarbonyl)indole-2-boronic acid;1H-Indole<wbr>-1,7-dica<wbr>rboxylic <wbr>acid, 2-b<wbr>orono-, 1<wbr>-(1,1-dim<wbr>ethylethy<wbr>l) 7-meth<wbr>yl ester | C15H18BNO6 |
| 953411-08-0 | B-(5-Methyl-1H-indol-2-yl)boronic acid | C9H10BNO2 |
| 953411-10-4 | 7-Bromo-1H-indazol-5-amine | C7H6BrN3 |
| 953411-16-0 | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazol-3-amine | C13H18BN3O2 |
| 953414-75-0 | 5-Bromo-2-Phenyl-1H-Pyrrolo[2,3-b]Pyridine;1H-Pyrrolo[2,3-B]Pyridine, 5-Bromo-2-Phenyl-;5-Bromo-2-Phenyl-1H-Pyrrolo[2,3-B]Pyridine | C13H9BrN2 |
| 953717-92-5 | 3-Amino-N-(4-fluorophenyl)benzenesulfonamide | C12H11FN2O2S |
| 953736-59-9 | 1-(Hexahydro-1H-1,4-diazepin-1-yl)-3,3-dimethyl-1-butanone | C11H22N2O |
| 953739-57-6 | 2-(4-Methyl-1-piperazinyl)-1-butanamine;[2-(4-methylpiperazin-1-yl)butyl]amine;2-(4-methyl-1-piperazinyl)-1-butanamine;2-(4-methylpiperazinyl)butylamine | C9H21N3 |
| 953749-60-5 | N<sup>1</sup>,N<sup>1</sup>-Dimethyl-1-(5-methyl-2-furyl)-1,2-ethanediamine;[2-amino-1-(5-methyl(2-furyl))ethyl]dimethylamine;N-[2-Amino-1-(5-methyl-2-furyl)ethyl]-N,N-dimethylamine;N<sup>1</sup>,N<sup>1</sup>-dimethyl<wbr>-1-(5-met<wbr>hyl-2-fur<wbr>yl)-1,2-e<wbr>thanediam<wbr>ine | C9H16N2O |
| 953769-46-5 | BLZ 945;4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide | C20H22N4O3S |
| 953778-58-0 | 4-(1-Methylethyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]benzeneacetamide | C20H23F3N2O2 |
| 953778-63-7 | 4-Cyclopropyl-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]benzeneacetamide | C20H21F3N2O2 |
| 953780-33-1 | (alphaR)-alpha-Methyl-5-(2,2,2-trifluoroethoxy)-2-pyridinemethanamine | C9H11F3N2O |
| 953780-42-2 | 5-Fluoro-6-methoxynicotinic acid;3-Fluoro-2-methoxy-5-pyridinecarboxylic acid;3-Fluoro-2-methoxy-5-pyridinecarboxylicacid | C7H6FNO3 |
| 953780-78-4 | (R)-3-Methylmorpholine hydrochloride | C5H11NO.HCl |
| 953787-54-7 | Lansoprazole sulfone N-oxide;2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzimidazole | C16H14F3N3O4S |
| 953789-37-2 | 1-[[2-(4-Chlorophenyl)ethyl]amino]-2-chloropropane hydrochloride | C11H15Cl2N.HCl |
| 953805-20-4 | (4S)-3-[4-[2-(4-Fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone | C25H28FNO5 |
| 953888-69-2 | 2-(4-Morpholinyl)-1-butanamine;(2-morpholin-4-ylbutyl)amine;2-(4-morpholinyl)-1-butanamine;2-morpholin-4-ylbutan-1-amine | C8H18N2O |
| 954123-46-7 | 1-Bromo-3-(bromomethyl)-5-(trifluoromethyl)benzene;3-Bromo-5-(trifluoromethyl)benzyl bromide | C8H5Br2F3 |
| 954126-98-8 | Danirixin;N-[4-Chloro-2-hydroxy-3-[(3S)-3-piperidinylsulfonyl]phenyl]-N'-(3-fluoro-2-methylphenyl)urea; GSK 1325756; GSK 1325756B | C19H21ClFN3O4S |
| 954137-48-5 | 5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene | C19H15Br |
| 954147-35-4 | (alphaS)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2H-tetrazole-5-propanoic acid | C19H17N5O4 |
| 954216-03-6 | 5-Bromo-N-(2-furylmethyl)-3-nitro-2-pyridinamine;(5-Bromo-3-nitro-pyridin-2-yl)-furan-2-ylmethyl-amine;5-Bromo-2-(furan-2-ylmethylamino)-3-nitropyridine;5-Bromo-N-(furan-2-ylmethyl)-3-nitropyridin-2-amine | C10H8BrN3O3 |
| 954219-68-2 | 2,3-Difluoro-5-nitropyridine | C5H2F2N2O2 |
| 954220-47-4 | 4-(Piperidin-4-yl)pyrimidine | C9H13N3 |
| 954222-10-7 | 4-Chloro-6-isopropylpyrimidine;4-chloro-6-(1-methylethyl)pyrimidine;4-chloro-6-(propan-2-yl)pyrimidine;4-Chloro-6-isopropyl-pyrimidine | C7H9ClN2 |
| 954222-94-7 | 3-(2-Chlorophenoxy)azetidine | C9H10ClNO |
| 954225-20-8 | 2-Oxo-1-(pyridin-3-ylmethyl)-1,2-dihydropyridine-3-carboxylic acid | C12H10N2O3 |
| 954225-35-5 | 2-(Bromomethyl)-5-fluoropyridine | C6H5BrFN |